Attralus Therapeutics

0 followers

‌

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Mark Timney

CEO

Mark Timney

Collapse

Spencer Guthrie

Co-Founder & COO

Glen Firestone

Chief Business Officer

Gregory Bell

Chief Medical Officer

Jonathan Wall

Co-Founder & Interim Chief Scientific Officer

James Testa

VP, Finance

Christine Huh

Head, Human Resources

Mike Klein

Senior Vice President, Head of CMC

Dave Conroy

Head of Program Management

Matthew Meldorf

Senior Vice President Clinical Development

Teams

+10

Regulatory and Scientific Development

13 members

Clinical Operations and Development

7 members

Leadership Team

6 members

Similar companies

Enko

4 followers

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Tango Therapeutics

2 followers

Kyverna Therapeutics

6 followers

Ultima Genomics

3 followers

Cellares

2 followers

eGenesis

1 follower

BioXcellerator

1 follower

ACELYRIN

1 follower

Thermo Fisher Scientific

173 followers

Explore companies